Skip to main content

OGSIVEO® (nirogacestat)

GOMEKLI® (mirdametinib)
844-CARES-55 (844-227-3755)Monday-Friday 8 AM-10 PM ET  844-227-3747
Gomekli logo
Gomekli logo

Personalized Educational & Emotional Support  

Our Nurse Advocates can provide treatment support as it relates to your condition, and can provide you information, discuss expectations on the treatment process, and answer questions about GOMEKLI® (mirdametinib).  
Support Img

Once you’re enrolled, one of our Nurse Advocates will welcome you and be your single point of contact at SpringWorks CareConnections, providing personalized educational and emotional support*:  

  • Provide you with information about your condition
  • Help you or your loved one stay on track and take GOMEKLI as prescribed
  • Answer questions to help you manage treatment for you or your loved one throughout the treatment journey
  • Help plan conversations with your care team
  • Help you understand treatment with GOMEKLI
  • Work with your doctor’s office and pharmacy so that you receive GOMEKLI as prescribed, including prescription refill reminders
Phone

Upon enrollment, expect a welcome call from a SpringWorks CareConnections Nurse Advocate to explain the program and what you can expect next.

The call will come from SpringWorks CareConnections (502‑805‑3473). Please add this number to your contact list so you recognize the call.

* The SpringWorks CareConnections Patient Support Program is not intended to take the place of your healthcare provider, and our team of Nurse Advocates cannot provide medical or clinical advice.
Cc Logo

Enrollment in SpringWorks

CareConnections is simple

Phone

Have Questions?

Call SpringWorks
CareConnections today

844-CARES-55
(844-227-3755)

Monday-Friday
8 AM-10 PM ET

© 2025 SpringWorks Therapeutics, Inc. All rights reserved. 
C_GOM_US_0082  08/25

OGSIVEO, GOMEKLI, and SpringWorks CareConnections are registered trademarks of SpringWorks Therapeutics, Inc. All other trademarks are the property of their respective owners.

This site is intended for U.S. audiences only.